Trinity Biotech plc (NASDAQ: TRIB) Stock Competitors & Peer Comparison
See TRIB's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TRIB and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRIB | $6.69 | -1.04% | 142.8M | -0.12 | -$60.60 | N/A |
| ALC | $65.26 | +1.22% | 31.8B | 20.52 | $3.18 | +0.55% |
| STE | $208.95 | +0.01% | 20.6B | 20.25 | $10.42 | +1.23% |
| MLAB | $131.68 | -1.76% | 744.2M | 13.42 | $9.91 | +0.48% |
| QDEL | $10.73 | -1.92% | 738.5M | 8.08 | $1.34 | N/A |
| BWAY | $13.25 | -0.45% | 519.7M | 33.66 | $0.39 | N/A |
| MASS | $11.62 | +1.57% | 478.4M | -19.43 | -$0.60 | N/A |
| SI | $17.82 | +4.86% | 372M | -10.37 | -$1.73 | N/A |
| MOBI | $9.16 | +1.10% | 293.6M | -4.58 | -$1.93 | N/A |
| LAB | $0.72 | -2.66% | 284.7M | -10.39 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
TRIB vs ALC Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, ALC has a market cap of 31.8B. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while ALC trades at $65.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas ALC's P/E ratio is 20.52. In terms of profitability, TRIB's ROE is +0.68%, compared to ALC's ROE of +0.03%. Regarding short-term risk, TRIB is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check ALC's competition here
STERIS plc (NYSE: STE)
TRIB vs STE Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, STE has a market cap of 20.6B. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while STE trades at $208.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas STE's P/E ratio is 20.25. In terms of profitability, TRIB's ROE is +0.68%, compared to STE's ROE of +0.11%. Regarding short-term risk, TRIB is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
TRIB vs MLAB Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, MLAB has a market cap of 744.2M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while MLAB trades at $131.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas MLAB's P/E ratio is 13.42. In terms of profitability, TRIB's ROE is +0.68%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, TRIB is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MLAB's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
TRIB vs QDEL Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, QDEL has a market cap of 738.5M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while QDEL trades at $10.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas QDEL's P/E ratio is 8.08. In terms of profitability, TRIB's ROE is +0.68%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, TRIB is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check QDEL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
TRIB vs BWAY Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, BWAY has a market cap of 519.7M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while BWAY trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas BWAY's P/E ratio is 33.66. In terms of profitability, TRIB's ROE is +0.68%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, TRIB is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
TRIB vs MASS Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, MASS has a market cap of 478.4M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while MASS trades at $11.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas MASS's P/E ratio is -19.43. In terms of profitability, TRIB's ROE is +0.68%, compared to MASS's ROE of -0.25%. Regarding short-term risk, TRIB is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
TRIB vs SI Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, SI has a market cap of 372M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while SI trades at $17.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas SI's P/E ratio is -10.37. In terms of profitability, TRIB's ROE is +0.68%, compared to SI's ROE of -0.26%. Regarding short-term risk, TRIB is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
TRIB vs MOBI Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, MOBI has a market cap of 293.6M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while MOBI trades at $9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas MOBI's P/E ratio is -4.58. In terms of profitability, TRIB's ROE is +0.68%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, TRIB is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
TRIB vs LAB Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, LAB has a market cap of 284.7M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while LAB trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas LAB's P/E ratio is -10.39. In terms of profitability, TRIB's ROE is +0.68%, compared to LAB's ROE of -0.18%. Regarding short-term risk, TRIB is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
TRIB vs ANIK Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, ANIK has a market cap of 276.8M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while ANIK trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas ANIK's P/E ratio is 42.20. In terms of profitability, TRIB's ROE is +0.68%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, TRIB is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
TRIB vs EDAP Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas EDAP's P/E ratio is -5.80. In terms of profitability, TRIB's ROE is +0.68%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, TRIB is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
TRIB vs NYXH Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while NYXH trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas NYXH's P/E ratio is -0.64. In terms of profitability, TRIB's ROE is +0.68%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, TRIB is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
TRIB vs APYX Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, APYX has a market cap of 105.3M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while APYX trades at $2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas APYX's P/E ratio is -12.50. In terms of profitability, TRIB's ROE is +0.68%, compared to APYX's ROE of -0.79%. Regarding short-term risk, TRIB is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
TRIB vs SKIN Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, SKIN has a market cap of 84.2M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while SKIN trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas SKIN's P/E ratio is -2.95. In terms of profitability, TRIB's ROE is +0.68%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, TRIB is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
TRIB vs MDAI Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, MDAI has a market cap of 51.2M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while MDAI trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas MDAI's P/E ratio is -3.58. In terms of profitability, TRIB's ROE is +0.68%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, TRIB is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
TRIB vs DRIO Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, DRIO has a market cap of 49.1M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while DRIO trades at $6.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas DRIO's P/E ratio is -1.15. In terms of profitability, TRIB's ROE is +0.68%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, TRIB is more volatile compared to DRIO. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
TRIB vs BEAT Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, BEAT has a market cap of 20.7M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas BEAT's P/E ratio is -0.73. In terms of profitability, TRIB's ROE is +0.68%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, TRIB is more volatile compared to BEAT. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check BEAT's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
TRIB vs MDAIW Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, MDAIW has a market cap of 14.5M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while MDAIW trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas MDAIW's P/E ratio is -1.28. In terms of profitability, TRIB's ROE is +0.68%, compared to MDAIW's ROE of N/A. Regarding short-term risk, TRIB is more volatile compared to MDAIW. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MDAIW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
TRIB vs BEATW Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, BEATW has a market cap of 6.3M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas BEATW's P/E ratio is -0.02. In terms of profitability, TRIB's ROE is +0.68%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, TRIB is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
TRIB vs WOK Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, WOK has a market cap of 4.5M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while WOK trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas WOK's P/E ratio is N/A. In terms of profitability, TRIB's ROE is +0.68%, compared to WOK's ROE of -0.19%. Regarding short-term risk, TRIB is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
TRIB vs QTEXW Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, TRIB's ROE is +0.68%, compared to QTEXW's ROE of N/A. Regarding short-term risk, TRIB is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
TRIB vs ITOC Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while ITOC trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas ITOC's P/E ratio is -0.89. In terms of profitability, TRIB's ROE is +0.68%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, TRIB is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
TRIB vs FEED Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas FEED's P/E ratio is -0.15. In terms of profitability, TRIB's ROE is +0.68%, compared to FEED's ROE of -0.60%. Regarding short-term risk, TRIB is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
TRIB vs TIVC Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 142.8M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, TRIB is priced at $6.69 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.12, whereas TIVC's P/E ratio is -0.04. In terms of profitability, TRIB's ROE is +0.68%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, TRIB is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check TIVC's competition here